Why ‘being squeezed’ helps breast cancer cells to thrive
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2026 02:15 ET (23-Jun-2026 06:15 GMT/UTC)
A new study led by researchers at Adelaide University and published in Science Advances has revealed why some cancers can grow and survive in the body, while others cannot.
Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors. The study, just published in JAMA Network Open, is one of the first to explore sex differences in cardiometabolic risk factors for liver fibrosis, a condition on the rise globally. Data came from the U.S. Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey. The researchers included data from 5,981 U.S. adults, representative of the U.S. population with an average age of 47, collected between 2017 and 2020. They analyzed whether the link between liver fibrosis and key cardiometabolic risk factors differed by sex, including waist circumference, high blood pressure, diabetes or pre-diabetes, high triglycerides, low high-density lipoprotein (HDL) cholesterol and the presence of two or more of these factors. In their statistical analysis, the researchers controlled for age, race, ethnicity, smoking and alcohol intake to rule out the influence of those factors. Overall, women faced similar or lower baseline rates of liver fibrosis compared with men. However, when certain risk factors were present, women’s fibrosis rates tended to increase more sharply than men. For example, high waist circumference was associated with an increase in fibrosis rates from 0.8% to 9.2% in women (about 11-fold), compared with an increase from 4.4% to 17.0% in men (about fourfold). Type 2 diabetes or pre-diabetes was linked to a 2.8-fold increase in fibrosis rates among women, versus a 1.4-fold increase among men. Having two or more cardiometabolic risk factors was associated with an 8.4-fold increase in women, compared to a 2.6-fold increase in men. The findings underscore that maintaining good heart and metabolic health has implications well beyond heart disease prevention.
Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are poorly understood.
Therapeutic antibodies are among the most widely used biologic medicines, yet detecting subtle structural differences in these complex proteins remains challenging. Researchers in Japan have established a nuclear magnetic resonance (NMR) strategy that reveals residue-specific structural features of antibodies without the need for isotope labeling.
The approach enables atomic-level evaluation of antibody structure, glycosylation, and molecular dynamics, providing a practical platform for quality assessment of biologic drugs and biosimilars.
Cisplatin (Cis) is an anticancer agent used to treat several types of cancers, including testicular cancer. However, despite its therapeutic efficacy, it increases the levels of reactive oxygen species (ROS), which damage healthy tissues and cells, resulting in tissue toxicity. This study aimed to examine the healing effect of selenium (Se) on Cis-induced testicular injury in male rats by evaluating testicular weight and monitoring the levels of oxidative stress and reproductive function markers in testicular homogenates.
This March, join the Alliance for Clinical Trials in Oncology (Alliance) and the Alliance Foundation Trials (AFT) in spotlighting colorectal cancer, the second leading cause of cancer-related death in the United States, behind only lung cancer, according to the National Cancer Institute. Last year, an estimated 155,000 Americans received a diagnosis of colon or rectal cancer, and about 53,000 died from the disease. Alliance has 10 active trials focused on improving treatments for colorectal cancers as well as others aimed at ways to prevent the disease or catch it very early when symptoms are most easily and effectively treated.